GAO Report on CMMI Performance: Challenges and Recommendations

The Government Accountability Office (GAO) has released an evaluative report on the Center for Medicare and Medicaid Innovation's (CMMI) performance from 2011 to 2024. This assessment, requested by House Budget Chairman Jodey Arrington and former Health Care Task Force Chairman Rep. Michael Burgess, scrutinizes the efficiency of CMMI's initiatives, particularly concerning healthcare cost reduction and quality enhancement.

Chairman Arrington highlighted significant concerns, noting CMMI's limited success, with only 4 out of 70 models achieving their desired outcomes—equating to a mere 5 percent success rate. The GAO report underscores the importance of improving regulatory compliance and accountability within CMMI, especially against the backdrop of rising national debt and fiscal challenges.

Originally established under the Affordable Care Act to explore innovative healthcare models, CMMI faced financial challenges, as reported by the Congressional Budget Office (CBO). From Fiscal Year 2011 to 2020, CMMI incurred a $5.4 billion net loss, spending $7.9 billion on models that yielded just $2.6 billion in savings. The CBO projects that CMMI's activities may further elevate federal spending by $1.3 billion over the next decade.

The GAO identified several operational inefficiencies within CMMI, including considerable levels of unobligated funds, slow implementation progress, and flawed model testing durations. Additionally, CMMI's quality metrics have been criticized for inadequately measuring patient care quality, evidenced by a 5.7 percent success rate of models effectively integrated into federal healthcare programs. This calls for enhanced model design and improved quality assurance practices.